ArticleScientific reports2026
Non-thermal atmospheric pressure plasma inactivation of Paenibacillus larvae, the causative agent of American foulbrood in honeybees (Apis mellifera).
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
American foulbrood (AFB), caused by Paenibacillus larvae, is a major threat to honeybee (Apis mellifera) health. This study evaluated the antimicrobial efficacy of direct non-thermal atmospheric pressure plasma (NTAPP) against P. larvae and its effects on bacterial infectivity in honeybee larvae. Air and argon plasma treatments significantly inhibited bacterial growth on agar, producing inhibition zones up to 17.5 mm, and reduced viable counts to 5.21–5.54 log CFU/mL (p < 0.0001). Plasma exposure compromised membrane integrity, as evidenced by increased leakage of intracellular nucleic acids and proteins, resulting in a 5.49–36.21% reduction in viable cells depending on the plasma conditions. Consistently, SEM analysis revealed pronounced plasma-induced morphological alterations in P. larvae cells. Larvae fed with plasma-treated P. larvae, particularly air plasma–treated cells, exhibited markedly reduced bacterial loads. However, Kaplan–Meier survival analysis showed no significant differences in larval survival among treatment groups, indicating that although plasma treatment reduced bacterial viability, this effect did not translate into improved larval survival under the conditions tested. Overall, NTAPP effectively reduced P. larvae viability, demonstrating its antimicrobial potential against this pathogen. Further optimization, particularly targeting spore inactivation, is required to enhance its impact on larval survival and support practical applications in apiculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.